COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 mixed. The earliest on record is from 2021.
Replications
- Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology, Errington et al. (2021). eLife. Outcome recorded: mixed.
"To summarize, we found results that were in the same direction as the original study and statistically significant where predicted.""To summarize, we found results that were in the opposite direction as the original study and not statistically significant."
Outcome read from the full text. View paper
Cite this record
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., Caponigro, G., Hieronymus, H., Murray, R. R., Salehi-Ashtiani, K., Hill, D. E., Vidal, M., Zhao, J. J., Yang, X., Alkan, O., … Garraway, L. A. (2010). COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature, 468(7326), 968–972. https://doi.org/10.1038/nature09627
Other studies in the atlas
Failed replications · Successful replications · All browse pages